ClinicalTrials.gg
CompletedNCT07139249Updated Oct 27, 2026

Impact of Gender Difference and Exercise Intensities on Depression and Anxiety Symptoms Among University Students

An interventional study of The high intensity interval training and The study moderate continuous training in Depression, Anxiety and University Students, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Updated Oct 27, 2026Now CompletedEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 20 studies in Depression by Cairo University — 7 open to participants now, 7 under way, none of them phase 3. Depression · Cairo University.

Enrollment
4th of 17
84 · median 50
Started
2025
with 3 others
No phase
16 of 20
6 open now
Registered
14th of 20
by date

Among the 20 studies in Depression by Cairo University, this one is the 4th largest by enrollment of the 17 interventional ones that give a count, is one of 4 that started in 2025, is one of 16 with no phase, and was the 14th registered.

Depression

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

Browse Depression studies →

Open to participants now

7 of the 20 studies in Depression by Cairo University are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,089 Depression studies recruiting now, 470 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 311 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Depression by Cairo University, or all of them as a file.
02

Study summary

This study was done to investigate the impact of gender differences and exercise intensities on depression and anxiety symptoms among university students

Read the detailed description

Depression among university students is a growing concern due to factors such as separation from family, transition to a performance-based environment, financial stressors, and uncertainty about postgraduation. An estimated 71% of Egyptian university students have at least minor depression. Depression is associated with lower academic performance and can lead to substance abuse, chronic conditions, and premature mortality. Despite the availability of effective treatment, only one in five university students receives minimally adequate treatment. Physical exercise is suggested as an affordable, low-cost, non-pharmacological treatment for depression and anxiety. Exercise can effectively relieve anxiety symptoms, and a study will evaluate depression and anxiety symptoms based on gender and exercise intensity among university students.

03

Conditions studied

  • Depression
  • Anxiety
  • University Students
  • Gender
  • Exercise Intensity
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a student in higher education
  • Being single
  • Age between 18 and 25 years of both sexes
  • Accepting the principle of randomization in the trial.
  • The is 18.5-24.9 kg/m².
  • Diagnosed by psychiatrist as having a mild to moderate degree of anxiety and depression.
  • Having scores of 7-24 on the Hamilton Rating Scale for Depression.
  • Having scores of 17-30 on the Hamilton Anxiety Rating Scale.

Exclusion criteria

Exclusion Criteria:

  • Neurological history such as illness or head trauma
  • Present severe and unstable respiratory disease
  • History of heart defect or cardiovascular disease or any other medical conditions prohibiting high-intensity sport or physical activity
  • Being professional athlete.
  • Involved in regular routine of exercises
  • Taking medication for mental health history of any neurological disorders like neuropathy or seizures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    females with high intensity interval training

    It will consist of 14 female students; they will be receiving high intensity interval training.

    Other: The high intensity interval training

  • Active comparator
    males with high intensity interval training

    It will consist of 14 male students; they will be receiving high intensity interval training.

    Other: The high intensity interval training

  • Experimental
    females with moderate intensity continuous training.

    It will consist of 14 female students; they will be receiving moderate intensity continuous training

    Other: The study moderate continuous training

  • Active comparator
    males with moderate intensity continuous training.

    It will consist of 14 male students; they will be receiving moderate intensity continuous training

    Other: The study moderate continuous training

  • No intervention
    The non-exercise females group

    It will consist of 14 female students; they will remain sedentary for the six-weeks intervention period.

  • No intervention
    The non-exercise males group

    It will consist of 14 male students; they will remain sedentary for the six-weeks intervention period

Interventions

  • OtherThe high intensity interval training

    The training program for students in groups 1 and 2 involves high intensity interval training exercises, conducted three times per week for six weeks. The sessions include a 10-minute warm-up at 40% Heart Rate Reserve, four high-intensity work periods at 85-95% Heart Rate Reserve, three low-intensity work periods at 60-70% Heart Rate Reserve, and a 5- 10 minute cool down at 30% Heart Rate Reserve.

  • OtherThe study moderate continuous training

    All students in groups 3\&4 will receive moderate continuous training 3 times per week for 6 weeks. Each session 40 to 50 minutes included a 5 to 10 minute warm-up, fo followed by 30 minutes of moderate aerobic exercise (treadmill walking exercise) with constant intensity at 60% to 70% Heart Rate Reserve and 5 to 10 minutes cool-down

06

What researchers measure

Primary outcomes

  1. assessment of the severity of depressive symptoms

    The Hamilton Rating Scale for Depression will be used to assess the severity of depressive symptoms in students across six groups. The 17-item version ranges from 0 to 54, with scores ranging from 0 to 24. Scores between 0 and 6 indicate no depression, while scores between 7 and 17 indicate mild, 18-24 indicate moderate, and 24+ over 24 indicate severe depression. A decrease in scores of at least 50% indicates response, and scores of 7 or less after treatment indicate remission. The 17-item version has adequate reliability and validity.

    Time frame: at baseline and after 6 weeks

Secondary outcomes

  1. assessment of severity of perceived anxiety symptoms

    The Hamilton Rating Scale for Anxiety is a tool used to assess the severity of perceived anxiety symptoms. It consists of 14 symptom-defined elements, scoring from 0 to 4 (severe). The score range is 0 to 56, with scores above 17/56 indicating mild anxiety, 25-30 indicating moderate anxiety, and \>30 indicating severe anxiety. It has good psychometric properties.

    Time frame: at baseline and after 6 weeks

  2. assessment of physical fitness

    The Harvard Step Test is a physical fitness index that measures an individual's ability to recover from muscular work and perform muscular tasks. It is performed on a 33 cm bench at 30 steps per minute, with heart rate measured every two seconds. The test is valid for estimating the cardiorespiratory fitness of college students and can be divided into three categories: excellent, good, average, and poor. The physical efficiency index rating ranges from 96 to 115, with the highest rating being excellent for males and the lowest being poor. The test is a reliable tool for assessing physical fitness.

    Time frame: at baseline and after 6 weeks

  3. assessment of heart rate during exercise

    A pulse oximeter will be used to continuously monitor heart rate during exercise, ensuring the target heart rate (THR) remains within the pre-calculated value. The heart rate will be measured and monitored for all participants using the Karvonen formula. The process involves cleaning the index finger, placing the pulse oximeter on the index, and keeping the pulse for at least a minute until the reading stabilizes.

    Time frame: at baseline and after 6 weeks

07

Study locations

1 site
  • out-patient clinic, faculty of physical therapy, Horus university
    Damietta, Egypt
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Jan 2026, 5 months.

Of 3,471 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 5 months is below that.

Counting every sponsor, half of 3,569 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2025
First posted
Aug 24, 2025
StartActual
Aug 20, 2025
Primary completionActual
Jan 20, 2026
CompletionActual
Feb 1, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Not yet recruiting→Completed
    + 3 other changes: verification date, date precision and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07139249
Lead sponsor
Cairo University
Responsible party
Aya Mohammed Hassan (principal investigator, Cairo University) — Principal investigator
First posted
Aug 24, 2025
Start date
Aug 20, 2025
Primary completion
Jan 20, 2026
Completion
Feb 1, 2026
Last update
Oct 27, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion